Skip to content

CareDx

US · CDNA #2371 by market cap Listed 1970
70.00 -1.92 -2.67%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 44 in the most recent period (2026/Q3).
  • Total institutional ownership fell 8.4 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
97.77% -8.42pp
Institutions
328 +44
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund67.48%
Hedge Fund24.17%
Public Company3.32%
Individual/Insider3.29%
Private Company1.22%
Government Pension Fund0.86%
Family Office/Trust0.42%
Insurance Company0.28%

Top holders as of 2026-09-30

BlackRock 9.27% · 4.87M sh
State Street Global Advisors 4.99% · 2.62M sh
Vanguard Capital Management, LLC 4.17% · 2.19M sh
Deerfield Management Company, L.P. 3.80% · 2.00M sh
Baron Capital Group, Inc. 3.69% · 1.94M sh
ARK Investment Management LLC 3.06% · 1.61M sh
Boston Partners Global Investors, Inc. 3.75% · 1.94M sh
Geode Capital Management, LLC 2.82% · 1.48M sh
Gagnon Securities, LLC 3.15% · 1.63M sh
Chevy Chase Trust Company 2.74% · 1.44M sh
Ophir Asset Management Pty Ltd 2.41% · 1.26M sh
Renaissance Technologies Corp. 2.39% · 1.26M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 11 buys · 39 sells

NameRoleStake
Peter Maag Former Independent Director 0.56%
Abhishek Jain Former Chief Financial Officer 0.48%
Michael Goldberg Independent Chairperson 0.27%
John Hanna Chief Executive Officer 0.26%
Fred Cohen Independent Director 0.25%
George Bickerstaff Independent Director 0.24%
Jeffrey Novack General Counsel 0.19%
Keith Kennedy Chief Financial Officer 0.10%
William Hagstrom Former Independent Director 0.08%
Alexander Johnson Former President of Patient & Testing Services 0.08%
Jessica Meng Chief Commercial Officer 0.08%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-09 George Bickerstaff Independent Director Derivative Exercise and Retained +15,000 $14.74
2026-11-09 Jeffrey Novack General Counsel Automatic Disposition -4,096 $80.47–83.33
2026-11-05 Jeffrey Novack General Counsel Sale to Issuer -1,505 $78.56
2026-11-04 Keith Kennedy Chief Financial Officer Automatic Disposition -9,539 $79.49–83.60
2026-11-04 Keith Kennedy Chief Financial Officer Derivative Exercise and Sale -52,422 $29.43–79.49
2026-11-02 Fred Cohen Independent Director Other Disposition -25,000 --
2026-10-31 Jeffrey Novack General Counsel Sale to Issuer -2,873 $85.88
2026-10-01 Michael Goldberg Independent Chairperson Other Acquisition +588 --
2026-09-30 Keith Kennedy Chief Financial Officer Sale to Issuer -3,018 $66.23
2026-09-30 John Hanna Chief Executive Officer Sale to Issuer -8,511 $66.23
2026-09-30 Jessica Meng Chief Commercial Officer Sale to Issuer -2,619 $66.23
2026-09-30 Jeffrey Novack General Counsel Sale to Issuer -997 $66.23
2026-09-11 Keith Kennedy Chief Financial Officer Sale to Issuer -8,220 $52.37
2026-09-11 Jessica Meng Chief Commercial Officer Sale to Issuer -6,688 $52.37
2026-08-16 Peter Maag Former Independent Director Intent to Sell (Form 144) -9,122 $46.38
2026-08-13 Peter Maag Former Independent Director Intent to Sell (Form 144) -7,000 $45.30
2026-08-12 Peter Maag Former Independent Director Intent to Sell (Form 144) -7,000 $47.07
2026-08-11 Peter Maag Former Independent Director Intent to Sell (Form 144) -7,000 $46.89
2026-08-10 Peter Maag Former Independent Director Intent to Sell (Form 144) -7,000 $47.69
2026-08-09 Peter Maag Former Independent Director Intent to Sell (Form 144) -6,902 $47.66

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:02:25 · For reference only, not investment advice and not tailored to your situation.

CareDx discussion 0 comments

Add a comment